Cas no 849725-39-9 (Sodium 5'-Inosinate hydrate(2:1:7))
Sodium 5'-Inosinate hydrate(2:1:7) Chemical and Physical Properties
Names and Identifiers
-
- Sodium 5'-Inosinate hydrate(2:1:7)
- AK552014
- Disodium;[3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl phosphate;heptahydrate
- 5′-Inosinic acid, disodium salt, heptahydrate (9CI)
- Disodium inosine 5′-monophosphate heptahydrate
- Sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl phosphate heptahydrate
- Inosine-5'-monophosphate Disodium Salt heptahydrate
- disodium heptahydrate [(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)oxolan-2-yl]methyl phosphate
- Inosine-5'-monophosphateDisodiumSaltheptahydrate
- disodium [(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl phosphate heptahydrate
- D83751
- CS-0160306
- disodium;[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl phosphate;heptahydrate
- ZIB72539
- 849725-39-9
-
- MDL: MFCD30536239
- Inchi: 1S/C10H13N4O8P.2Na.8H2O/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17;;;;;;;;;;/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H2,18,19,20);;;8*1H2/t4-,6-,7-,10-;;;;;;;;;;/m1........../s1
- InChI Key: KROOSEOAPHJIAJ-NAGQJCCQSA-N
- SMILES: O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C=NC2C(N=CNC1=2)=O.[Na].O.[Na].O.O.O.O.O.O.O
Computed Properties
- Exact Mass: 518.08494166g/mol
- Monoisotopic Mass: 518.08494166g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 10
- Hydrogen Bond Acceptor Count: 17
- Heavy Atom Count: 32
- Rotatable Bond Count: 3
- Complexity: 544
- Covalently-Bonded Unit Count: 10
- Defined Atom Stereocenter Count: 4
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 188
Sodium 5'-Inosinate hydrate(2:1:7) Security Information
- Signal Word:Warning
- Hazard Statement: H302-H315-H319-H335
- Warning Statement: P261-P305+P351+P338
- Storage Condition:Inert atmosphere,2-8°C
Sodium 5'-Inosinate hydrate(2:1:7) Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Ambeed | A165095-1g |
Sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl phosphate heptahydrate |
849725-39-9 | 98% | 1g |
$5.0 | 2023-06-15 | |
| Ambeed | A165095-5g |
Sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl phosphate heptahydrate |
849725-39-9 | 98% | 5g |
$10.0 | 2024-07-24 | |
| Ambeed | A165095-10g |
Sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl phosphate heptahydrate |
849725-39-9 | 98% | 10g |
$15.0 | 2024-07-24 | |
| Ambeed | A165095-25g |
Sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl phosphate heptahydrate |
849725-39-9 | 98% | 25g |
$31.0 | 2024-07-24 | |
| Ambeed | A165095-100g |
Sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl phosphate heptahydrate |
849725-39-9 | 98% | 100g |
$259.0 | 2025-02-22 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-WL441-20g |
Sodium 5'-Inosinate hydrate(2:1:7) |
849725-39-9 | 98+% | 20g |
329.0CNY | 2021-07-10 | |
| Chemenu | CM255288-25g |
Sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl phosphate heptahydrate |
849725-39-9 | 97% | 25g |
$102 | 2022-09-28 | |
| Chemenu | CM255288-100g |
Sodium ((2R,3S,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl phosphate heptahydrate |
849725-39-9 | 97% | 100g |
$*** | 2023-05-29 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-WL441-1g |
Sodium 5'-Inosinate hydrate(2:1:7) |
849725-39-9 | 98+% | 1g |
40CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-WL441-5g |
Sodium 5'-Inosinate hydrate(2:1:7) |
849725-39-9 | 98+% | 5g |
102.0CNY | 2021-07-10 |
Sodium 5'-Inosinate hydrate(2:1:7) Related Literature
-
Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
-
Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
-
Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
-
Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
Additional information on Sodium 5'-Inosinate hydrate(2:1:7)
Research Brief on Sodium 5'-Inosinate hydrate(2:1:7) and Related Compound 849725-39-9
This research brief provides an overview of the latest findings related to Sodium 5'-Inosinate hydrate(2:1:7) and its associated compound with the CAS number 849725-39-9. These compounds are of significant interest in the field of chemical biology and pharmaceutical research due to their potential applications in drug development and biochemical studies. The brief synthesizes recent academic literature and industry reports to present a cohesive understanding of their properties, mechanisms, and potential uses.
Sodium 5'-Inosinate hydrate(2:1:7) is a nucleotide derivative that plays a crucial role in various biochemical pathways. Recent studies have highlighted its utility as a flavor enhancer in the food industry and its potential therapeutic applications in modulating immune responses. The compound's hydrate form, with a specific stoichiometric ratio of 2:1:7, has been the subject of renewed interest due to its enhanced stability and solubility, which are critical for pharmaceutical formulations.
The compound with the CAS number 849725-39-9, often referenced in conjunction with Sodium 5'-Inosinate hydrate(2:1:7), has been investigated for its role as an intermediate in the synthesis of bioactive molecules. Recent research has focused on its structural properties and reactivity, which make it a valuable building block in medicinal chemistry. Advanced spectroscopic techniques and computational modeling have been employed to elucidate its behavior in various chemical environments.
One of the key findings from recent studies is the synergistic effect observed when Sodium 5'-Inosinate hydrate(2:1:7) is combined with other nucleotides. This synergy has been leveraged in the development of novel drug formulations aimed at enhancing bioavailability and reducing side effects. Additionally, the compound's role in nucleotide metabolism has been explored, with implications for treating metabolic disorders and cancers.
In conclusion, the ongoing research into Sodium 5'-Inosinate hydrate(2:1:7) and 849725-39-9 underscores their importance in both industrial and therapeutic contexts. Future studies are expected to further unravel their mechanisms and expand their applications, particularly in personalized medicine and targeted drug delivery systems. This brief serves as a foundation for researchers looking to explore these compounds in greater depth.
849725-39-9 (Sodium 5'-Inosinate hydrate(2:1:7)) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)